BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  AstraZeneca CEO Knighted by Queen for COVID-19 Leadership

  AstraZeneca CEO Pascal Soriot has been knighted in the Queen’s Birthday Honours for his contribution to life sciences and leadership during the COVID-19 pandemic.

  June 2, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, MS
• 

  Business

  Seattle’s Sana Biotech Shifts Manufacturing to Bothell, Washington, Adds Key Leaders

  Seattle-based Sana Biotechnology is moving on from its current Fremont, California manufacturing facility, inking a lease deal to develop a manufacturing plant in Bothell, Washington.

  June 2, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Another Journal Retracts Paper Co-Authored by Cassava Sciences Key Collaborator

  Cassava Sciences is reeling after another journal retracted an article co-authored by a key collaborator on its experimental Alzheimer’s disease therapeutic, simufilam.

  June 2, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Novel TCR Therapy Shows Tentative Promise Against Pancreatic Cancer

  Researchers at the Earle A. Chiles Research Center have successfully shrunk a woman’s pancreatic cancer tumors using a novel immunotherapy.

  June 2, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano M.S.
• 

  Job Trends

  Evonik to Build $220M Lipid Plant in U.S. for mRNA-Based Therapies

  In partnership with the U.S. government, Evonik Industries is investing more than $200 million to build a lipid manufacturing facility in the United States.

  June 2, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  BMS-Backed Transition Bio Scores $50M to Mine Biomolecular Condensates for Therapeutic Use

  Transition Bio has a four-component platform called Condensomics which provides a technological method to understand the properties of condensates.

  June 2, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Business

  Upstream Bio Dives into Severe Asthma Space with $200M in Series A Financing

  Upstream Bio is focusing its efforts on an experimental treatment for severe asthma licensed from Astellas Pharma.

  June 2, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Deals

  Regeneron to Buy Sanofi’s Stake in Libtayo for $900M Upfront

  Regeneron Pharmaceuticals announced intentions to acquire Sanofi’s stake in a drug they developed together, Libtayo (cemiplimab).

  June 2, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  J&J and BMS Drugs Reduce COVID-19 Deaths in Moderate-to-Severe Population

  Bristol Myers Squibb’s Orencia and Johnson & Johnson’s Remicade improved survival rates for people hospitalized with COVID-19 according to a new report by the National Institutes of Health.

  June 2, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Flagship’s Tessera Wins Services of Ex-AbbVie Exec Severino

  Tessera Therapeutics announced Thursday that ex-AbbVie executive Michael Severino, M.D. will take the helm of the young biotech.

  June 2, 2022

   · 

  2 min read

   · 

  Paul Besabella